|
1
|
Singh D, Vignat J, Lorenzoni V, Eslahi M,
Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F and
Vaccarella S: Global estimates of incidence and mortality of
cervical cancer in 2020: A baseline analysis of the WHO global
cervical cancer elimination initiative. Lancet Glob Health.
11:e197–e206. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li M, Du X, Lu M, Zhang W, Sun Z, Li L, Ye
M, Fan W, Jiang S, Liu A, et al: Prevalence characteristics of
single and multiple HPV infections in women with cervical cancer
and precancerous lesions in Beijing, China. J Med Virol.
91:473–481. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin S, Gao K, Gu S, You L, Qian S, Tang M,
Wang J, Chen K and Jin M: Worldwide trends in cervical cancer
incidence and mortality, with predictions for the next 15 years.
Cancer. 127:4030–4039. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shami S and Coombs J: Cervical cancer
screening guidelines: An update. JAAPA. 34:21–24. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Awolude OA, Oyerinde SO, Ayeni AO and
Adewole IF: Human papillomavirus-based cervical precancer screening
with visual inspection with acetic acid triage to achieve same-day
treatments among women living with human immunodeficiency virus
infection: test-of-concept study in Ibadan, Nigeria. Pan Afr Med J.
40:482021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao H, He Y, Fan B, Wang Y and Wu YM:
Human papillomavirus E6E7 mRNA and TERC lncRNA in situ detection in
cervical scraped cells and cervical disease progression assessment.
Virol J. 19:182022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong A, Xu B, Wang Z and Miao X:
Survival-related DLEU1 is associated with HPV infection status and
serves as a biomarker in HPV-infected cervical cancer. Mol Med Rep.
25:772022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lyu Y, Ding L, Gao T, Li Y, Li L, Wang M,
Han Y and Wang J: Influencing factors of high-risk human
papillomavirus infection and DNA load according to the severity of
cervical lesions in female coal mine workers of China. J Cancer.
10:5764–5769. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Horn J, Denecke A, Luyten A, Rothe B,
Reinecke-Lüthge A, Mikolajczyk R and Petry KU: Reduction of
cervical cancer incidence within a primary HPV screening pilot
project (WOLPHSCREEN) in Wolfsburg, Germany. Br J Cancer.
120:1015–1022. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jary A, Teguete I, Sidibé Y, Kodio A, Dolo
O, Burrel S, Boutolleau D, Beauvais-Remigereau L, Sayon S, Kampo M,
et al: Prevalence of cervical HPV infection, sexually transmitted
infections and associated antimicrobial resistance in women
attending cervical cancer screening in Mali. Int J Infect Dis.
108:610–616. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu H, Zhao J, Yu W, Zhao J, Wang Z, Jin L,
Yu Y, Han L, Wang L, Zhu H and Li F: Human papillomavirus DNA, HPV
L1 capsid protein and p16(INK4a) protein as markers to predict
cervical lesion progression. Arch Gynecol Obstet. 299:141–149.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bedell SL, Goldstein LS, Goldstein AR and
Goldstein AT: Cervical cancer screening: past, present, and future.
Sex Med Rev. 8:28–37. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Dong B, Zhang Q, Mao X, Lin W,
Ruan G, Kang Y and Sun P: HR-HPV viral load quality detection
provide more accurate prediction for residual lesions after
treatment: A prospective cohort study in patients with high-grade
squamous lesions or worse. Med Oncol. 37:372020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sargent A, Fletcher S, Bray K, Kitchener
HC and Crosbie EJ: Cross-sectional study of HPV testing in
self-sampled urine and comparison with matched vaginal and cervical
samples in women attending colposcopy for the management of
abnormal cervical screening. BMJ Open. 9:e0253882019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okunade KS: Human papillomavirus and
cervical cancer. J Obstet Gynaecol. 40:602–608. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hernández-López R, Lorincz AT,
Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, Nedjai
B, Mendiola-Pastrana I, León-Maldonado L, Rivera-Paredez B, et al:
Methylation estimates the risk of precancer in HPV-infected women
with discrepant results between cytology and HPV16/18 genotyping.
Clin Epigenetics. 11:1402019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santesso N, Mustafa RA, Schünemann HJ,
Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H,
Eckert LO, et al: World health organization guidelines for
treatment of cervical intraepithelial neoplasia 2–3 and
screen-and-treat strategies to prevent cervical cancer. Int J
Gynaecol Obstet. 132:252–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zehua W: Obstetrics and gynecology (5th
edition). Obstetrics Gynecol. (5th Edition). 2004.
|
|
19
|
Perkins RB, Guido RS, Castle PE, Chelmow
D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, et
al: 2019 ASCCP risk-based management consensus guidelines for
abnormal cervical cancer screening tests and cancer precursors. J
Low Genit Tract Dis. 24:102–131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y: Investigation of the clinical
application value of HR-HPV DNA combined with liquid based cytology
in colposcopy of cervical cancer. Contrast Media Mol Imaging.
2022:50545072022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abdel Aziz MT, Abdel Aziz MZ, Atta HM,
Shaker OG, Abdel Fattah MM, Mohsen GA, Ahmed HH and El Derwi DA:
Screening for human papillomavirus (HPV) in Egyptian women by the
second-generation hybrid capture (HC II) test. Med Sci Monit.
12:MT43–MT49. 2006.PubMed/NCBI
|
|
22
|
Poljak M, Marin IJ, Seme K, Brinovec V,
Maticic M, Meglic-Volkar J, Lesnicar G and Vince A:
Second-generation Hybrid capture test and Amplicor monitor test
generate highly correlated hepatitis B virus DNA levels. J Virol
Methods. 97:165–169. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Knoepp SM, Kuebler DL and Wilbur DC:
Resolution of equivocal results with the Hybrid Capture II
high-risk HPV DNA test: A cytologic/histologic review of 191 cases.
Diagn Mol Pathol. 16:125–129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Burness JV, Schroeder JM and Warren JB:
Cervical colposcopy: Indications and risk assessment. Am Fam
Physician. 102:39–48. 2020.PubMed/NCBI
|
|
25
|
Zhou Q, Zhang F, Sui L, Zhang H, Lin L and
Li Y: Application of 2011 international federation for cervical
pathology and colposcopy terminology on the detection of vaginal
intraepithelial neoplasia. Cancer Manag Res. 12:5987–5995. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kudela E, Laucekova Z, Nachajova M,
Visnovsky J, Bielik T, Krivus S, Biringer K, Balharek T and Zubor
P: Colposcopic scoring indexes in the evaluation of cervical
lesions with the cytological result of atypical squamous cells,
cannot exclude high-grade lesion. J Obstet Gynaecol Res.
46:314–319. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McCluggage WG, Judge MJ, Alvarado-Cabrero
I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M,
et al: Data set for the reporting of carcinomas of the cervix:
Recommendations from the international collaboration on cancer
reporting (ICCR). Int J Gynecol Pathol. 37:205–228. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao X, Song S, Wang Y, Mu X and Zhang L:
Effects of photodynamic therapy in the treatment of high-grade
vaginal intraepithelial lesions following hysterectomy and HPV
infection. Photodiagnosis Photodyn Ther. 42:1033362023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Lu F and Yin Y: Applying logistic
LASSO regression for the diagnosis of atypical Crohn's disease. Sci
Rep. 12:113402022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rajaram S and Gupta B: Screening for
cervical cancer: Choices & dilemmas. Indian J Med Res.
154:210–220. 2021.PubMed/NCBI
|
|
31
|
Ping W: Application value of HPV test in
cervical cancer screening of rural women. J Community Med.
14:22016.
|
|
32
|
Rohner E, Edelman C, Sanusi B, Schmitt JW,
Baker A, Chesko K, Faherty B, Gregory SM, Romocki LS, Sivaraman V,
et al: Extended HPV genotyping to compare HPV type distribution in
self- and provider-collected samples for cervical cancer screening.
Cancer Epidemiol Biomarkers Prev. 29:2651–2661. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jespersen MM, Booth BB and Petersen LK:
Can biopsies be omitted after normal colposcopy in women referred
with low-grade cervical cytology? A prospective cohort study. BMC
Womens Health. 21:3942021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Du Y, Dong J, Zhou Y, Wang P,
Zhang X, Chen Y and He P: Clinical significance of genotyping for
human papillomavirus (HPV) 16 18/45 combined with cytology in
cervical exfoliated cells in HPV oncogenic mRNA-positive women.
Gynecol Oncol. 153:34–40. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu XH, Li XM, Zhang WL, Liao MM, Li Y,
Wang FF, Shang B, Peng LG, Su YJ, You ZJ, et al: Application of
artificial intelligence-assisted diagnosis for cervical
liquid-based thin-layer cytology. Zhonghua Bing Li Xue Za Zhi.
50:333–338. 2021.(In Chinese). PubMed/NCBI
|
|
36
|
Wittenborn J, Weikert L, Hangarter B,
Stickeler E and Maurer J: The use of micro RNA in the early
detection of cervical intraepithelial neoplasia. Carcinogenesis.
41:1781–1789. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang SK, Luo XP, Li ZF, Su Z, Xia JC, Hu
GY, Zhu YJ, Xie LX, Feng XX, Sun XB, et al: Performance of human
papillomavirus typing test in cervical precancer lesions and
cervical cancer screening. Zhonghua Zhong Liu Za Zhi. 42:252–256.
2020.(In Chinese). PubMed/NCBI
|
|
38
|
Newman H, Hu J, Li X, He J, Bradford L,
Shan S, Wu X, Zhu B, Yang W, Fu B, et al: Evaluation of portable
colposcopy and human papillomavirus testing for screening of
cervical cancer in rural China. Int J Gynecol Cancer. 29:23–27.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cong Q, Song Y, Wang Q, Zhang H, Gao S and
Sui L: A retrospective study of cytology, high-risk HPV, and
colposcopy results of vaginal intraepithelial neoplasia patients.
Biomed Res Int. 2018:58948012018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luo GP, Zeng X, Cao HY, Tang D and Xi MR:
The clinical significance of HPV L1/PD-L1 tests combined with
colposcopy for cervical precancerous lesions and cervical cancer.
Sichuan Da Xue Xue Bao Yi Xue Ban. 52:516–522. 2021.(In Chinese).
PubMed/NCBI
|
|
41
|
Liu Y, Liao J, Yi X, Pan Z, Pan J, Sun C,
Zhou H and Meng Y: Diagnostic value of colposcopy in patients with
cytology-negative and HR-HPV-positive cervical lesions. Arch
Gynecol Obstet. 306:1161–1169. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Luo Q, Lang L, Han N, Liang L, Shen L and
Zhang H: Prevalence and genotype distribution of high-risk human
papillomavirus infection among women with cervical cytological
abnormalities in Chongqing, China, 2014–2020. Diagn Cytopathol.
49:1237–1243. 2021. View
Article : Google Scholar : PubMed/NCBI
|
|
43
|
Painter H, Erlinger A, Simon B, Morroni C,
Ramogola-Masire D and Luckett R: Impact of cervicitis on
performance of cervical cancer screening using HRHPV testing and
visual evaluation in women living with HIV in Botswana. Int J
Gynaecol Obstet. 151:144–146. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu G, Sharma M, Tan N and Barnabas RV:
HIV-positive women have higher risk of human papilloma virus
infection, precancerous lesions, and cervical cancer. Aids.
32:795–808. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vodicka EL, Chung MH, Zimmermann MR,
Kosgei RJ, Lee F, Mugo NR, Okech TC, Sakr SR, Stergachis A,
Garrison LP Jr and Babigumira JB: Estimating the costs of HIV
clinic integrated versus non-integrated treatment of pre-cancerous
cervical lesions and costs of cervical cancer treatment in Kenya.
PLoS One. 14:e02173312019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Husaiyin S, Han L, Wang L, Ma C, Ainiwaer
Z, Rouzi N, Akemujiang M, Simayil H, Aniwa Z, Nurimanguli R and
Niyazi M: Factors associated with high-risk HPV infection and
cervical cancer screening methods among rural Uyghur women aged
>30 years in Xinjiang. BMC Cancer. 18:11622018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Garza-Rodríguez ML, Oyervides-Muñoz MA,
Pérez-Maya AA, Sánchez-Domínguez CN, Berlanga-Garza A,
Antonio-Macedo M, Valdés-Chapa LD, Vidal-Torres D, Vidal-Gutiérrez
O, Pérez-Ibave DC and Treviño V: Analysis of HPV integrations in
mexican pre-tumoral cervical lesions reveal centromere-enriched
breakpoints and abundant unspecific HPV regions. Int J Mol Sci.
22:32422021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dong B, Chen L, Lin W, Su Y, Mao X, Pan D,
Ruan G, Xue H, Kang Y and Sun P: Cost-effectiveness and accuracy of
cervical cancer screening with a high-risk HPV genotyping assay vs.
a nongenotyping assay in China: An observational cohort study.
Cancer Cell Int. 20:4212020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ferrera A, Valladares W, Cabrera Y, de la
Luz Hernandez M, Darragh T, Baena A, Almonte M and Herrero R:
Performance of an HPV 16/18 E6 oncoprotein test for detection of
cervical precancer and cancer. Int J Cancer. 145:2042–2050. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Suwanthananon C and Inthasorn P: A
comparison of the associations of reid colposcopic index and swede
score with cervical histology. J Obstet Gynaecol Res. 46:618–624.
2020. View Article : Google Scholar : PubMed/NCBI
|
